US 7582605
Phosphorus-containing hepatitis C serine protease inhibitors
granted A61KA61K38/21
Quick answer
US patent 7582605 (Phosphorus-containing hepatitis C serine protease inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K38/21